To the full analysis
SI-BONE stock: growth
SIBNSI-BONE reported $200.93M in revenue for fiscal 2025, up 20.2% on the prior year, up 22.3% a year on average over up to five years.
Daily figure as of 13 Nov 2026
Revenue (Annual rate)
13.9%
per year from 2012 to 2025, per share −10.5%
Earnings (Annual rate)
no data
Free cash flow (Annual rate)
no data
Growth per year by period
What reaches shareholders is growth per share: buybacks lift it, new shares dilute it.
| since 2020 | since 2015 | since 2012 | |
|---|---|---|---|
| Revenue | 22.3% | 17.2% | 13.9% |
| Revenue per share | 12.8% | 10.4% | −10.5% |
| Earnings | no data | no data | no data |
| Earnings per share | no data | no data | no data |
| Free cash flow | no data | no data | no data |
| Free cash flow per share | no data | no data | no data |
Fiscal years at a glance
How revenue and earnings grow
- Revenue
- Earnings
- Free cash flow
Figures as a table
| Year | Revenue | Earnings | Free cash flow |
|---|---|---|---|
| 2012 | $37.02M | −$10.9M | −$14.8M |
| 2013 | $49M | −$6.15M | −$1.3M |
| 2014 | $40.05M | −$27.81M | −$29.2M |
| 2015 | $41.17M | −$28.15M | −$28.96M |
| 2016 | $42.1M | −$20.59M | −$17.19M |
| 2017 | $47.98M | −$23.04M | −$18.01M |
| 2018 | $55.38M | −$17.45M | −$15.46M |
| 2019 | $67.3M | −$38.4M | −$34.07M |
| 2020 | $73.39M | −$43.7M | −$33.22M |
| 2021 | $90.15M | −$56.57M | −$45.92M |
| 2022 | $106.41M | −$61.26M | −$51.16M |
| 2023 | $138.89M | −$43.34M | −$26.51M |
| 2024 | $167.18M | −$30.91M | −$22.92M |
| 2025 | $200.93M | −$18.91M | −$9.09M |
Revenue by region
Where SI-BONE, Inc. generates its revenue.
- United States95%
- Outside the US5%
Figures as a table
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Share 2025 | |
|---|---|---|---|---|---|---|---|---|---|
| United States | $50.14M | $61.84M | $68.12M | $82.74M | $98.75M | $130.62M | $158.42M | $191.08M | 95.1% |
| Outside the US | $5.24M | $5.46M | $5.27M | $7.41M | $7.66M | $8.27M | $8.76M | $9.85M | 4.9% |
| Total revenue | $55.38M | $67.3M | $73.39M | $90.15M | $106.41M | $138.89M | $167.18M | $200.93M | 100% |
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 31 Dec 2025
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Weak, published since 7 Nov 2026 (in the score history since 31 Oct 2019)
- Valuation signal Overvalued since 7 Nov 2026
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.